Bronchial hyperreactivity and immunoglobulin E in Behçet's disease

Area of Science:

• Rheumatology
• Pulmonology
• Immunology

Background:

• Behçet's disease (BD) is a rare multisystem vasculitis with unknown causes.
• Pulmonary involvement in BD is uncommon, and specific markers for disease activity are lacking.
• Differentiating active from inactive BD, especially in pulmonary cases, requires reliable indicators.

Purpose of the Study:

• To investigate bronchial hyperreactivity (BHR) and serum total IgE levels in BD patients.
• To determine if BHR or IgE can serve as specific markers for active BD.
• To explore the relationship between these markers and disease chronicity or activity.

Main Methods:

• A methacholine challenge test was used to measure BHR in 31 BD patients and 10 healthy controls.
• Serum total IgE concentrations were measured in all participants.
• Patients were assessed for active lesions and disease history, excluding other pulmonary or allergic conditions.

Main Results:

• Elevated IgE levels were observed in patients with active lesions, but the difference was not statistically significant (p > 0.05).
• High IgE levels were found in 25.81% of BD patients, independent of disease activity.
• Bronchial hyperreactivity (BHR) was positive in 25.81% of patients, significantly associated with longer disease duration (p < 0.05).

Conclusions:

• Bronchial hyperreactivity (BHR) may reflect nonspecific inflammation in Behçet's disease (BD).
• BHR is associated with disease chronicity but is not a specific marker for active BD.
• Serum IgE levels and BHR are not reliable indicators for differentiating active from inactive BD.